Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > rel-N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]benzamide
rel-N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]benzamide structure, CAS 1035270-39-3

rel-N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]benzamide

CAS Number1035270-39-3

SynonymsAZD4547; azd 4547; qcr-89; N-{5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl}-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]benzamide

Molecular FormulaC26H33O3N5

Molecular Weight463.58

Purity

Density1.2±0.1 g/cm3

Boiling Point621.7±55.0 °C at 760 mmHg

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-1174310 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 1035270-39-3 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number1035270-39-3
Catalog No.2A-1174310
Chinese NameAZD4547
SynonymsAZD4547; azd 4547; qcr-89; N-{5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl}-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]benzamide
Molecular FormulaC26H33O3N5
Molecular Weight463.58
Density1.2±0.1 g/cm3
Boiling Point621.7±55.0 °C at 760 mmHg
Storage ConditionRoom temperature, dry, sealed
ApplicationAZD4547 is a potent FGFR family inhibitor, targeting FGFR1, FGFR2, FGFR3 and FGFR4 with IC50 of 0.2 nM, 2.5 nM, 1.8 nM and 165 nM respectively.
PubChem ID117699613
MDL NumberMFCD22580423
SMILESCOc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1
InChIInChI=1S/C26H33N5O3/c1-17-15-31(16-18(2)27-17)22-9-6-20(7-10-22)26(32)28-25-13-21(29-30-25)8-5-19-11-23(33-3)14-24(12-19)34-4/h6-7,9-14,17-18,27H,5,8,15-16H2,1-4H3,(H2,28,29,30,32)/t17-,18+
InChI KeyVRQMAABPASPXMW-HDICACEKSA-N
MSDSmsds/174656_1_1035270_39_3.pdf
Transport InfoProduct name: AZD4547
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA